1. Гуревич К.Г. Какие фосфолипиды «эссенциальнее»? Клин. фармакол. 2004; 1: 1–5.
2. Strecker A. Uber einige neue Bestandtheile der Schweingalle. Ann Chem Pharmacie 1862; 123: 353–60.
3. Best CH, Huntsman ME. Effect of choline on liver fat of rats in various states on nutrition. J Physiol 1935; 83: 255–74.
4. Best CH, Huntsman ME. The effects of the components of lecithin upon the deposition of fat in the liver. J Physiol 1932; 75: 405–12.
5. Davis A. Let's Eat Right to keep fit. New York: Penguin, USA, 1970.
6. Zeisei SH. Choline. Shils ME, Olson JA, Shike M. Modern Nutrition in Health and Disease. 8th ed. Philadelphia: Lea Febiger, 1994; p. 449–58.
7. Yates J. Lecithin works wonders. Prevention 1980; 32: 55–9.
8. Zeisei SH. Choline phospholipids: signal transduction and carcinogenesis. FASEB J 1993; 7: 551–7.
9. Zeisei SH. Choline: an important nutrient in brain development, liver function and carcinogenesis. J Am Coll Nutr 1992; 11: 473–81.
10. Буеверов А.О., Ешану В.С., Маевская М.В., Ивашкин В.Т. Эссенциальные фосфолипиды в комплексной терапии стеатогепатита смешанного генеза. Клин.
перспективы гастроэнтерол., гепатол. 2008; 1: 17–22.
11. DaCosta KA, Cochary EF, Blusztajn JK et al. Accumulation of 1,20sn-diradylglycerol with increased membraneassociated protein kinase C may be the mechanism for spontaneous hepatocarcinogenesis in choline deficient rats. J Biol Chem 1993; 268: 2100–5.
12. Zeisei SH, DaCosta KA, Franklin PD. Choline, an essencial nutrient for humans. FASEB J 1991; 5: 2093–8.
13. Sheard NF, Tayek JA, Bistrian BR et al. Plasma choline concentration in humans fed parenterally. Am J Clin Nutr 1986; 43: 219–24.
14. Buchman AL, Dubin M, Jenden D et al. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology 1992; 102: 1363–70.
15. Lieber CS, DeCarli LM, Mak KM et al. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 1990; 12: 1390–8.
16. Гундерманн К., Кундирович М. Применение «эссенциальных» фосфолипидов при сахарном диабете. Обзор международных результатов. Пробл. эндокринол. 1994; 40 (3): 59–62.
17. Hsia SL, He JL, Nie Y et al. The hypocholesterolemic and antiatherogenic effects of topically applied phosphatidylcholine in rabbits with heritable hypercholesterolemia.
Artery 1996; 22: 1–23.
18. O'Brien BC, Andews VG. Influence of dietary egg and soybean phospholipids and triacylglycerols on human serum lipoproteins. Lipids 1993; 28: 7–12.
19. Klimov AN, Konstantinov VO, Lipovetsky BM et al. «Essential» phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease. Cardiovasc Drugs Ther 1995; 9: 779–84.
20. Резникова М.М. Лечение эритродермий. РМЖ. 1998; 6 (6): 7–12.
21. Rivera-Penera T, Gugig R, Davis J et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 1997; 130: 300–4.
22. Ушкалова Е. А. Место эссенциальных фосфолипидов в современной медицине. Фарматека. 2003; 10 (73): 10–5.
23. Гундерманн К. Новейшие данные о механизмах действия и клинической эффективности эссенциальных фосфолипидов. Клин. перспективы гастроэнтерол.,
гепатол. 2002; 2: 28–31.
24. USDA. Continuing Survey of food intakes by individuals, 1989–91. Washington, DC: United States Department of Agriculture, 1992.
25. USDA. USDA Nationwide Food Consumption Survey, 1977–78. Washington, DC: United States Department of Agriculture, 1979.
26. Lehtinen P, Laakso S. Role of lipid reactions in quality of oat products. Agricultural and food science 2004; 13: 88–9.
Авторы
И.Г.Пахомова, Ю.П.Успенский
Санкт-Петербургская государственная медицинская академия им. И.И.Мечникова